Therapeutic Effect of Chang'an I Recipe (肠安I 号方) on Irritable Bowel Syndrome with Diarrhea: A Multicenter Randomized Double-Blind Placebo-Controlled Clinical …

X Tang, B Lu, Z Li, W Wei, L Meng, B Li, Z Tang… - Chinese journal of …, 2018 - Springer
Objective To evaluate the efficacy and safety of Chinese medicine (CM) decoction Chang'an
I Recipe (肠安I 号方) in the treatment of irritable bowel syndrome with diarrhea (IBS-D) …

[HTML][HTML] Efficacy and safety of Qinghua Zhixie Decoction against diarrhea-predominate irritable bowel syndrome: A protocol for a randomized controlled trial

L Ji, X Zhao, Y Zhang, P Zhao, R Gong, F Li, H Huang - Medicine, 2022 - journals.lww.com
Background: Diarrhea-predominant irritable bowel syndrome (D-IBS) is the main subtypes of
irritable bowel syndrome (IBS). In recent years, more than half of IBS patients have received …

[HTML][HTML] The Chinese herbal formula Huoxiang Zhengqi for diarrhea-predominant irritable bowel syndrome (CHAIRS): a study protocol for a double-blinded …

X Guo, M Xuan, H Zheng, S Qin, H Wu, S Huang… - Trials, 2021 - Springer
Background Diarrhea-predominant irritable bowel syndrome (IBS-D) is a common chronic
digestive disease. Recent observational studies have reported that the Chinese herbal …

[HTML][HTML] Efficacy and safety of Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome: study protocol for a multi-center, randomized, double …

Y Zheng, J Ching, CW Cheng, WC Lam, KL Chan… - Chinese Medicine, 2021 - Springer
Background Irritable bowel syndrome (IBS) is a common gastrointestinal functional disease.
Adults with IBS may experience abdominal pain, change of bowel habits, and abnormal …

[HTML][HTML] Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo …

SB Liang, M Han, HJ Cheng, QY Zhang, NW Zhang… - Trials, 2022 - Springer
Introduction Diarrhea-predominant irritable bowel syndrome (IBS-D) is a bowel disease with
a high incidence. It significantly reduces the quality of life of patients and affects the patient's …

Treating irritable bowel syndrome with diarrhea patients by yigan fupi decoction: a randomized controlled trial

MX Chen, JX Chen, L Xia, R Fu, Z Lu - Zhongguo Zhong xi yi jie he …, 2014 - europepmc.org
Objective To evaluate the efficacy and safety of Yigan Fupi Decoction (YFD) in the treatment
of irritable bowel syndrome with diarrhea (IBS-D) patients. Methods A randomized controlled …

Randomized controlled clinical study on effect of Chinese compound changjitai in treating diarrheic irritable bowel syndrome

Y Shen, G Cai, X Sun - Zhongguo Zhong xi yi jie he za zhi Zhongguo …, 2003 - europepmc.org
To verify the clinical efficacy and safety of the proven Chinese Compound Changjitai (CJT),
in treating the diarrheic irritable bowel syndrome (DIBS). Randomized controlled open …

[HTML][HTML] External therapy of traditional Chinese medicine for treating irritable bowel syndrome with diarrhea: A systematic review and meta-analysis

X Wei, Y Wen, Y Wei, X Liang, X Ma, B Zhang… - Frontiers in …, 2022 - frontiersin.org
Background Irritable bowel syndrome with diarrhea (IBS-D) is a chronic functional
gastrointestinal disorder that has a significant impact on quality of life, work productivity, and …

[HTML][HTML] Traditional Chinese medicine (Shun-Qi-Tong-Xie Granule) for irritable bowel syndrome: study protocol for a randomised controlled trial

X Wang, R Luo, B She, Y Chen, J Guo - Trials, 2014 - Springer
Background Irritable bowel syndrome (IBS) is a common gastrointestinal functional disorder
with no effective therapy. Traditional Chinese medicine (TCM) is one of the most common …

[PDF][PDF] Efficacy of Shenlingbaizhu formula on irritable bowel syndrome: a systematic review.

W Yuxian, Z Shengsheng, Z Qiang… - Journal of Traditional …, 2020 - researchgate.net
OBJECTIVE: To evaluate the effectiveness and safety of a Shenlingbaizhu (SLBZ) formula in
the treatment of irritable bowel syndrome (IBS). The effectiveness of SLBZ with or without …